Elizabeth Louise Hohmann MD
Associate Professor of Medicine, Massachusetts General Hospital
Join to View Full Profile
55 Fruit Street Grb 5Infectious Disease AssociatesBoston, MA 02114
Phone+1 617-724-7532
Fax+1 617-726-7416
Dr. Hohmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1990 - 1994
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine Start of enrollment: 2011 Jan 01
- Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum Start of enrollment: 2012 Nov 01
- Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsThird-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, Chia-Chi Chang, Areej El-Jawahri
Blood Advances. 2024-05-14 - 12 citationsPrevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.Charles S Berenson, Bret Lashner, Louis Y Korman, Elizabeth Hohmann, Abhishek Deshpande
Clinical Infectious Diseases. 2023-11-30 - 41 citationsSafety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Sin...Matthew D Sims, Sahil Khanna, Paul Feuerstadt, Thomas J Louie, Colleen R Kelly
JAMA Network Open. 2023-02-01
Other
- Microbiology and epidemiology of salmonellosisHohmann EL
http://www.uptodate.com/contents/microbiology-and-epidemiology-of-salmonellosis
UpToDate, Wolters Kluwer Health - 2013-03-26 - Approach to the patient with nontyphoidal Salmonella in a stool cultureHohmann EL
http://www.uptodate.com/contents/approach-to-the-patient-with-nontyphoidal-salmonella-in-a-stool-cul
UpToDate, Wolters Kluwer Health - 2013-01-18 - Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid feverHohmann EL
http://www.uptodate.com/contents/epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-
UpToDate, Wolters Kluwer Health - 2012-07-30 - Join now to see all
Press Mentions
Cambridge Microbiome Company Looks Beyond Fecal TransplantsJuly 6th, 2022- Why Tests for New Covid Drugs Are Delaying?June 17th, 2022
- Would You Take a Poop Pill?May 12th, 2022
- Join now to see all
Grant Support
- Fecal microbiota transplantation for auto-brewery syndromeUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2026
- Collaborative IRB Review And Ethical/Educational Exchange - Boston/DurbanFogarty International Center2010
- Human Studies Of Listeria Monocytogenes VectorsNational Institute Of Allergy And Infectious Diseases2002–2008
- Human Studies Of Attenuated Salmonella VectorsNational Institute Of Allergy And Infectious Diseases2005–2007
- Safety And Immunogenicity Of Attenuated Salmonella TyphimuriumNational Center For Research Resources2005–2006
- Safety &Shedding Of Attenuated Listeria Vaccine VectorsNational Center For Research Resources2000–2002
- Phop/Phoq Deleted S Typhi Vaccine StrainsNational Institute Of Allergy And Infectious Diseases1999–2002
- Safety And Immunogenicity Of Ty800 Carrying Heterologous AntigensNational Center For Research Resources1998–2002
- Deleted Phop/Phoq S Typhi As A Live Oral Vaccine VectorNational Institute Of Allergy And Infectious Diseases1997–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
